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Role of growth hormone in the development of experimental renal
scarring. Recent experimental data has implicated growth hormone in
the development of glomerular sclerosis, In this study, we have
examined the development and progression of glomerular and tubu-
lointerstitial scarring in Wistar and Dwarf rats, selectively growth
hormone-deficient, following subtotal nephrectomy. Wistar rats
showed progressive proteinuria, hypertension and renal failure as well
as severe renal scarring 120 days after subtotal nephrectomy. In
contrast, growth hormone-deficient Dwarf rats had minimal proteinuria,
mild renal functional impairment and moderate renal histological scar-
ring. The difference in these functional and structural parameters
between the two strains is highly significant, although both experimen-
tal groups had comparable food consumption and systemic blood
pressure. The significantly smaller glomeruli and limited kidney hyper-
trophy over 120 days observed in Dwarf rats may account for some of
the protection against glomerular sclerosis and tubulointerstitial scar-
ring observed in that strain.
Progressive renal scarring and failure occur in rats submitted
to extensive renal ablation [1]. Histologically such scarring is
characterized by progressive glomerular sclerosis as well as
severe tubular atrophy and dilatation [1]. The precise mecha-
nism and mediators of these structural changes remain un-
known. Recent evidence has implicated systemic hormones,
renal autacoids as well as peptide growth promoting factors in
the pathogenesis of renal scarring. Systemic hormones such as
growth hormone [2] and corticosteroids [3], autacoids such as
angiotensin II, and vasodilatory prostaglandins [4] and growth
factors such as insulin-like growth factor-I, epidermal growth
factor and transforming growth factor-f3 [5], have been put
forward as likely mediators of renal scarring.
The data implicating pituitary hormones, particularly growth
hormone, include the observations of attenuated spontaneous
glomerular sclerosis in hypophysectomized rats. These animals
seem to have limited age-related expansion of their glomerular
basement membrane and extracellular matrix [6]. They have
also been shown to be somewhat resistant to the development
of glomerular scarring after extensive renal ablation [7]. Con-
versely, transgenic mice expressing excess growth hormone
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(GH) are prone to an age-related accelerated form of glomerular
hypertrophy and sclerosis [2]. Similarly, hypertrophy of the
glomeruli is observed in transgenic mice expressing excess
insulin-like growth factor-I (IGF-I), although these mice do not
develop glomerular sclerotic lesions [2].
Until recently, studies of GH-deficiency in rodents was
confined to hypophysectomized rats or Dwarf mice. The recent
discovery of a new mutant strain of rats selectively deficient in
GH has stimulated research into the role of GH in the patho-
genesis of kidney scarring. These rats display a selective defect
in pituitary transcription of GH [8]. Consequently, their pitu-
itary and circulating GH concentration is 10% of normal and
they do not display the characteristic pulsatile response to
stimuli [81. We have previously shown that these rats are
capable of acute compensatory renal growth after limited renal
ablation [9]. In this study, we have studied their long-term
response to extensive renal ablation, and compared their func-
tional and histological parameters with those of Wistar rats.
Methods
Animals
Adult male Wistar rats (Sheffield University Field Laborato-
ries, UK) and Dwarf rats (Harlan Olac, UK) were studied. The
Wistar rats were three months old, weighed 351 6 g (mean
sEM) and had a body span of 25.6 0.56cm at the beginning of
the study. The Dwarf rats were age-matched, weighed 167 6
g and had a body span of 18.9 0.33 cm.
The rats were housed three to four to a cage at a constant
ambient temperature of 18°C and a humidity of 45% on a 12
hour light/dark cycle. The rats were not pair-fed but were
provided with a fixed daily amount of food and had free access
to tap water. They were housed in metabolic cages once a
month for collection of 24-hour urine samples.
Experimental protocol and assessments
Chronic renal failure was induced in both rat strains by
subtotal nephrectomy (SNx). Groups of 10 rats underwent a
one-stage subtotal nephrectomy consisting of the ligation and
resection of the left kidney's upper and lower poles as well as a
right uninephrectomy [1]. Control groups consisted of five
sham-operated rats. Rats were slightly underfed to guarantee
complete food consumption as Wistar rats were provided with
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16 g/rat/day of standard Purina chow (Labsure, Cambridge,
UK) while the Dwarfs received 12 g/rat/day throughout the
study. The diet contained 17.9% of protein and 0.32% of sodium
(approximately NaCl 100 mmol/kg). Food consumption, based
on measuring daily left-over food was undertaken weekly. Rats
were followed up for 120 days after SNx unless they had to be
sacrificed earlier because of uremic symptoms. In these rats
death from uremia was confirmed by serum creatinine.
After surgery, monthly measurements were made of body
weight, systolic blood pressure, serum and urine creatinine as
well as proteinuria. Rats were bled under light ether anaesthesia
from the tail artery. Creatinine was measured by parallel
analyzer (American Monitor, USA) and total urinary protein by
the Biuret method after precipitation with 20% trichloroacetic
acid, The systolic blood pressure was measured in awake,
restrained rats by indirect tail-cuff plethysmography [10]. At the
end of the experiment (day 120), rats were sacrificed and kidney
weight and morphology evaluated. Renal growth was deter-
mined by comparing the calculated weight of remnant kidneys
at surgery to that at sacrifice. Kidneys were processed for light
microscopy examination and the severity of the renal scarring
scored on an arbitrary scale from 0 to 4. The glomerular score
was: Grade 0, normal glomeruli; Grade 1, presence of mesangial
expansionlthickening of the basement membrane; Grade 2,
mild/moderate segmental hyalinosis/scierosis involving less
than 50% of the glomerular tuft; Grade 3, diffuse glomerular
hyalinosis/scierosis involving >50% of the tuft; Grade 4, diffuse
glomerulosclerosis with total tuft obliteration and collapse.
Glomerular scarring was also quantified by the assessment of
the percentage of glomeruli displaying significant sclerosis
(grade 2). A severity related arbitrary tubulointerstitial score
(0 to 4) was also applied [111. A glomerular score for each
animal was derived from the examination of 25 to 50 glomeruli.
For the determination of glomerular size (diameter/vol), 5 js
thick sections of formalin-fixed paraffin embedded kidneys were
stained with hematoxylin and eosin and analyzed under the light
microscope. The kidneys were sectioned horizontally passing
through both the cortex and the medulla. Fifty glomeruli from
each animal were measured starting at the kidney capsule and
working back and forth radially towards the medulla. This
procedure ensured that peripheral, central and juxtamedullary
glomeruli were sampled equally. Glomerular profile diameters
were measured using a digitizing tablet coupled to a desk-top
computer and linked to a light microscope via a drawing tube.
Measurements were made at a magnification of 195 times.
Glomerular profile diameters were measured in two planes at right
angles (a = major; b = minor axis) and mean profile diameter
taken as \/, From the total number of glomerular profiles for
each experimental group, size-frequency histograms (18 sm bin
size) were constructed. After correcting the left hand slopes of
these profile distributions for lost caps, the corrected distribu-
tions were calculated using the Schwartz-Saltykov unfolding
technique [12]. This technique compensates for the fact that
many of the glomeruli are not sectioned equatorially and hence
underestimate mean glomerular diameter. It uses the profile
distribution to construct, probabilistically, the true diameter
distribution. From these mean glomerular diameters and vol-
umes can be calculated. The morphological assessments were
undertaken by AMEN (light microscopy) and GHC (glomerular
volume measurements) without prior knowledge of the experi-
mental groups.
Statistical analysis
Results are expressed as median of the experimental group or
as mean standard error of the mean. The Mann-Whitney U
test was applied to assess the significance of the difference
between experimental groups. Difference in survival was eval-
uated by log rank test. The significance of correlations between
variables was assessed by linear regression analysis. A proba-
bility of 5% was used as the criterion of significance.
Results
General observations
Irrespective of the rat strains all rats recovered after subtotal
nephrectomy. Both experimental groups continued to grow at a
rate comparable to that of their respective control group.
However, the growth rate of control Dwarf rats was slightly
slower (33.1 2.8%) when compared to that of Wistar rats (38.9
4.1%; Fig. 1). Similarly, the increase in body span of Dwarf
rats (11.1 1.2%) was smaller than that of Wistar rats (33.1
4.5%). Food consumption was assessed weekly and found to be
complete in most experimental groups, with the exception of
groups of Wistar rats which developed severe renal failure by
days 90 to 120 when food consumption was incomplete. The
comparable consumption of food in the two strains was con-
firmed by the measurement of 24-hour urinary excretion of
urea, sodium and potassium. Urinary urea excretion in rats with
chronic renal failure was: Wistars, 1.9 0.8 mmoll24 hr/lOO g of
body weight; Dwarfs, 1.4 0.5 mmol/24 hr/l00 g. The median
sodium and potassium excretions were also comparable in the
two strains: Wistar (Na), 0.11 mmol/24 hr/tOO g; Dwarfs (Na),
0.15 mmol/24 hr/lOO g; Wistars (K), 0.2 mmol/24 hr/l00 g;
Dwarfs (K), 0.21 mmolJ24 hr/lOO g.
Blood pressure
Systolic blood pressure increased significantly in wistar rats
after SNx. By contrast, the blood pressure of Dwarf rats
remained within the normal range until day 30. Subsequently, a
steady and comparable increase in systemic blood pressure
took place in both experimental strains (Fig. 2). At sacrifice, the
heart fractional weight of nephrectomized rats, reflecting the
severity of the systemic hypertension, was comparable in the
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Fig. 1. Body weight (mean). Symbols are: sham (Wistar 0, Dwarf 0),
SNx (Wistar•, Dwarf ); *p < 0.001.
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Fig. 2. Systolic blood pressure (mean SEM). Symbols are: SNx
Wistar rats (s); SNx dwarf rats (0); < 0.05, Wistars compared to
Dwarfs on day 30 and Wistars day 30 compared to Wistars on day 0.
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Fig. 3. Proteinuria (mean SEM). Symbols are: SNx Wistar rats (•);
SNx Dwarf rats (0); *D < 0.001.
two nephrectomized strains (Wistars, 0.33 0.02 x 10—2 and
dwarfs, 0.36 0.02 x 10—2).
Proteinuria
Nephrectomized wistar rats develop a progressive increase in
24-hour urinary protein excretion, reaching in excess of a
ten-fold increase compared to controls (Fig. 3). The urine
volume and proteinuria of nephrectomized Dwarf rats remained
well within the normal range for their strain until day 60.
Subsequently, these rats had a threefold increase in proteinuria,
although it did not exceed 19.8 6.25 mg/24 hr by day 120. At
all stages, the difference in proteinuria between nephrectomized
Wistar and Dwarf rats was highly significant (P < 0.001).
Renal function
Following SNx, serum creatinine increased significantly in
both rat strains: Wistar, from 50.75 1.46 jsmol/liter to 93.4
5.2 p,mollliter; and Dwarfs, 47.25 0.48 molIliterto 66.5 1.93
mol/liter; P < 0.025. However, a progressive chronic renal
failure as defined by a steady increase in serum creatinine (Fig.
4) as well as a concomittant fall in creatinine clearance (Ce,.)
only took place in Wistar rats. In SNx Wistars, CCr fell from 182
lOpi/min/lo0gonday3oto 119 33 pl/minIl00gbyday 120.
This contrasted with an increase in CCr in the Dwarfs from 194
6 p,l/minIlOO g on day 30 to 299 26 d/min/100 g by day 120
(Fig. 4). Further, it is likely that the creatinine clearance of
Wistar rats between days 90 and 120 is an overestimate as rats
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Fig. 4. A. Serum creatinine (mean SEM). Symbols are: SNx Wistar
rats (•); SNx Dwarf rats (0); *<0.025; < 0.001. B. Creatinine
clearance (mean 5EM). J1 < 0.025, **D < 0.01.
who had to be sacrificed with severe uremic symptoms did not
have 24-hour urinary collections immediately prior to their
death. The difference between the two groups regarding serum
creatinine and creatinine clearance was highly significant (P <
0.025) by day 90.
Renal morphology
The kidney weight of Dwarf rats at surgery (0.67 0.04 g)
was significantly lighter than that of Wistars (0.98 0.08 g), P
<0.025. While normal kidney growth over the 120 experimental
days led to an increase in kidney weight of 31.4% (Wistars) and
16.6% (Dwarfs), considerably more hypertrophy took place in
nephrectomized animals. The extent of the SNx was compara-
ble in both groups: the median weight resected from the left
kidney of Wistar rats was 0.64 g (65% resected) while that
resected from Dwarf rats was 0.42 g (62% resected). Further-
more, the percentage value of the creatinine clearance at day 30
compared to day 0 was 63% and 68% for Wistars and Dwarfs,
respectively. At sacrifice, the percent increase in the remnant
kidney weight of Wistar rats was 509.4 84.3% compared to
267.4 62.5% for the Dwarfs, P < 0.025. The difference in
kidney growth between the two strains is likely to reflect
changes in kidney water content or tubular hypertrophy, as the
percentage increase in the glomerular size of nephrectomized
Dwarfs was, if anything, larger (+ 121%) than that of the
Wistars (+ 88%). In Wistar rats, a strong positive correlation
was observed between kidney weight and the severity of
glomerular (r = 0.73, P < 0.02) as well as tubulointerstitial
scarring (r — 0.81, P < 0.01).
At sacrifice, the median glomerular volume of control Dwarf
rats (0.88 x 106 m3) was significantly smaller than that of
Wistar rats (1.47 x 10 m3), P < 0.01. The glomerular volume
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of nephrectomized Wistar rats at sacrifice was 2.76 x 106 m3
compared to Dwarfs (1.95 x 106 sm3), P <0.01. In Wistar rats,
no correlation was found between glomerular volume and
kidney weight. A positive correlation was only observed when
Wistar and Dwarf rats were included: r = 0.711, P < 0.005.
The severity of glomerular and tubulointerstitial scarring was
considerably reduced in Dwarf rats compared to the Wistars.
Glomeruloscierosis was marked in nephrectomized Wistar rats
(3 0.16) compared to the Dwarfs (1.87 + 0.26), P < 0.01 (Fig.
5). A large percentage (76.1 4%) of glomeruli displayed
microaneurysms in Wistar rats compared to only 33.7 3% in
the nephrectomized Dwarfs, P < 0.01. In Wistar rats, no
significant correlation was observed between glomerular vol-
ume and sclerosis. When the two strains were combined, a
weak positive correlation was observed: r = 0.51, P < 0.02.
Tubulointerstitial scarring was characterized by severe diffuse
tubular atrophy, cystic dilatation of the tubules and interstitial
infiltrate in Wistar rats (score = 3.12 0.24) compared to mild
and more segmental lesions in the Dwarfs (score =2 0.30), P
< 0.02 (Fig. 5). Vascular (arteriolar) medial hypertrophy
seemed comparable in both strains.
Survival
In nephrectomized Wistar rats, six of ten rats had to be
sacrificed before the end of the experiment (between days 90
and 120) in view of advanced uremic signs (Fig. 6). The mean
serum creatinine of this group of rats was 232.8 26.1
molIliter, confirming the severity of their renal failure. No
death from uremia was recorded in the nephrectomized dwarf
group, (log rank test, P = 0.0028).
Discussion
Our observations show a marked improvement in the natural
history of the nephropathy that takes place after extensive renal
ablation in Dwarf, growth hormone (GH)-deficient, rats. This is
in agreement with data from hypophysectomized rats submitted
to a comparable reduction in functional renal mass where
glomerular scarring is attenuated [7]. It also supports the data
derived from the observation of accelerated spontaneous gb-
merulosclerosis in transgenic mice expressing high circulating
levels of GH, where this hormone was implicated in the
pathogenesis of glomerular hyperplasia and scarring [2].
From our data, we can only speculate as to the possible
mechanism of protection against renal scarring by GH defi-
ciency in Dwarf rats. Systemic hypertension, the increase in
glomerular capillary pressure and size as well as proteinuria
have been implicated in the development of glomerulosclerosis
[13]. In the two experimental strains studied in this experiment,
the severity of systemic hypertension was comparable. While a
delay in the rise of systolic blood pressure was observed in
Dwarf rats, it is unlikely to explain the different outcome
between the two strains. Further, such delay was not observed
in a preliminary study where the profile of the hypertensive
changes was identical in the two strains and severe glomerular
scarring did not take place in Dwarf rats [12]. It is well known
that in rats with remnant kidneys, glomeruloscierosis can be
prevented in spite of sustained systemic hypertension [1]. This
is the case when a low protein diet reduces glomerular capillary
pressure without affecting systemic hypertension [1, 14].
In this study we have not assessed the glomerular hemody-
namic changes that take place in the two rat strains following
renal ablation. A reduction of gbomerular capillary tension in
Dwarf rats can therefore only be speculative. The tension
generated on glomerular capillary walls is likely to be propor-
tional to the glomerular capillary pressure (PJ and to the
diameter of the capillary [15]. Difference in the expression of
P is known to be strain-dependent. For instance, PVG/c rats
fail to display an increase in filtration fraction after renal
ablation and are resistant to the development of severe glomer-
ular scarring [16]. Differences in glomerular size between
strains may also be relevant. In rats with renal ablation, the
increase gbomerular size is associated with an increase in the
diameter of their capillaries [17]. This may constitute a risk
factor for the development of glomerular hypertension and
subsequently sclerosis. Dwarf rats with small glomeruli may
therefore be protected from excessive glomerular capillary wall
tension in spite of early glomerular hypertrophy. This may in
turn explain the minimal proteinuria observed in these animals
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Fig. 6. Survival. SNx Wistar rats (•), SNx Dwarf rats (0). =
0.0028.
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after extensive renal ablation, as the severity of proteinuria in
this model is thought to reflect the degree of glomerular
hypertension [18]. Finally, the small glomerular size of Dwarf
rats may confer some protection against the development of
glomeruloscierosis. Similar observations regarding the protec-
tive advantage of small glomeruli have been made in nephrec-
tomized PVG/c rats [16]. Conversly, large glomeruli in mice
transgenic to the human GH gene [2] or to the large T antigen
gene (SV40) [19] seem to predispose to an accelerated form of
spontaneous glomerulosclerosis. In the latter, the severity of
such sclerosis is proportional to the size of the glomeruli [19]. A
large glomerular size has also been identified as a risk factor for
the development of focal and segmental glomeruloscierosis
(FSGS) in patients with minimal change nephrotic syndrome
[20]. Finally, therapeutic interventions, including anti-hyper-
tensive agents, capable of reducing glomerular hypertrophy in
rats with remnant kidneys prevent progressive glomeruloscler-
osis [21].
Growth hormone (GH) itself either directly or indirectly may
be involved in the development of glomerular sclerosis and
fibrosis. GH stimulates the proliferation of fibroblasts in vitro
[221. It also affects the concentration of proteoglycans within
vascular walls [23] and enhances the incorporation of proline
into collagen [24]. Finally, GH is also capable of increasing
renal IGF-I content. A rise of renal IGF-I content takes place
early in the course of renal ablation [25] and may contribute to
the development of glomerular sclerosis through its stimulation
of microvascular collagen and proteoglycan synthesis [26].
In our study, subtotally nephrectomized Dwarf rats had
considerably less tubulointerstitial scarring than their Wistar
counterparts. While considerable attention is being given to the
role of glomerulosclerosis in the development of progressive
renal insufficiency, experimental [11] and clinical [27] data also
suggest an important contribution of tubulointerstitial scarring.
Following subtotal nephrectomy in rats, tubular hypertrophy
and hypermetabolism takes place [28]. In our study, while
overall remnant kidney growth was more marked in Wistar rats,
glomerular hypertrophy was more marked in the Dwarfs. As the
wet weight of scarred kidneys reflects to a large extent their
water content, our observation would suggest a reduction of
kidney water in the Dwarf rats with attenuated renal scarring.
However, another explanation may be reduced compensatory
tubular hypertrophy in Dwarf rats. Excessive adaptive tubular
hypertrophy and hypermetabolism have been implicated in the
development of tubulointerstitial scarring and progressive renal
failure [28]. Both GH and IGF-I may be involved in adaptive
tubular hypertrophy. In acromegalic individuals the increase in
kidney weight is thought to reflect increased renal tubular mass
[29]. In the Dwarf rats, the attenuation of tubular growth in the
absence of GH may account for the limited renal hypertrophy.
This may contribute to the protection against severe tubuloin-
terstitial scarring and renal failure in these rats.
We believe that growth hormone plays a permissive role in
the development of experimental renal scarring. Thus, the rise
in circulating growth hormone during the course of chronic
renal failure may have a detrimental effect on the progression of
the underlying renal scarring process. Although acromegalic
patients do not seem to display an increased incidence of
glomerulosclerosis [29], it is possible that in the presence of an
underlying nephropatby high circulating levels of GH may be
detrimental. This may have important clinical implications as an
increasing number of uremic children are currently treated with
recombinant human growth hormone to correct their stunting.
So far this has not been associated with an acceleration of their
CRF. However, the earlier introduction of this form of therapy
may affect the progression of the underlying nephropathy in
these patients.
Clearly, further research is needed to confirm an association
between growth hormone and renal scarring. Reconstitution
experiments where Dwarf rats are supplemented with growth
hormone are warranted. Studies are also required to clarify the
mechanism of action of growth hormone in the pathogenesis of
glomerulosclerosis and tubulointerstitial scarring.
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